Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
17,194,910
-
Total 13F shares
-
1,870,266
-
Share change
-
+134,328
-
Total reported value
-
$4,600,000
-
Price per share
-
$2.46
-
Number of holders
-
17
-
Value change
-
+$329,181
-
Number of buys
-
10
-
Number of sells
-
3
Institutional Holders of Journey Medical Corp - Common Stock (DERM) as of Q3 2022
As of 30 Sep 2022,
Journey Medical Corp - Common Stock (DERM) was held by
17 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,870,266 shares.
The largest 10 holders included
B. Riley Financial, Inc., Opaleye Management Inc., PERKINS CAPITAL MANAGEMENT INC, AMERICAN FINANCIAL GROUP INC, Neuberger Berman Group LLC, FIRST MANHATTAN CO, GEODE CAPITAL MANAGEMENT, LLC, Cerity Partners LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, and Wealth Alliance Advisory Group, LLC.
This page lists
17
institutional shareholders reporting positions in this security
for the Q3 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.